New Zealand markets closed

bioMérieux S.A. (BMXMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
108.550.00 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 12.95B
Enterprise value 13.13B
Trailing P/E 33.28
Forward P/E 23.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.24
Price/book (mrq)3.15
Enterprise value/revenue 3.57
Enterprise value/EBITDA 15.86

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 31.92%
S&P500 52-week change 329.57%
52-week high 3114.00
52-week low 390.23
50-day moving average 3109.91
200-day moving average 3103.55

Share statistics

Avg vol (3-month) 362
Avg vol (10-day) 3N/A
Shares outstanding 5118.12M
Implied shares outstanding 6118.76M
Float 842.88M
% held by insiders 164.27%
% held by institutions 120.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.93
Forward annual dividend yield 40.86%
Trailing annual dividend rate 30.85
Trailing annual dividend yield 30.78%
5-year average dividend yield 4N/A
Payout ratio 428.24%
Dividend date 308 Jun 2017
Ex-dividend date 407 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.73%
Operating margin (ttm)7.76%

Management effectiveness

Return on assets (ttm)5.26%
Return on equity (ttm)8.73%

Income statement

Revenue (ttm)3.67B
Revenue per share (ttm)31.14
Quarterly revenue growth (yoy)-1.40%
Gross profit (ttm)N/A
EBITDA 827.6M
Net income avi to common (ttm)357.6M
Diluted EPS (ttm)3.27
Quarterly earnings growth (yoy)-12.70%

Balance sheet

Total cash (mrq)352.4M
Total cash per share (mrq)2.98
Total debt (mrq)518.8M
Total debt/equity (mrq)13.83%
Current ratio (mrq)2.03
Book value per share (mrq)31.78

Cash flow statement

Operating cash flow (ttm)445.4M
Levered free cash flow (ttm)135.44M